home / stock / mbio / mbio news

MBIO News and Press, Mustang Bio Inc. From 05/16/19

Stock Information
Company Name: Mustang Bio Inc.
Stock Symbol: MBIO
Market: NASDAQ
Website: mustangbio.com
Menu
MBIO MBIO Quote MBIO Short MBIO News MBIO Articles MBIO Message Board
Get MBIO Alerts

News, Short Squeeze, Breakout and More Instantly...
MBIO - GEVO, TRQ among premarket gainers

Iovance Biotherapeutics (NASDAQ: IOVA ) +36%  on positive TIL data . More news on: Iovance Biotherapeutics, Inc., CUI Global, Inc., MacroGenics, Inc., Stocks on the move, Read more ...

MBIO - Mustang Bio and Nationwide Children's Hospital Receive Orphan Drug Designation for MB-108 (Oncolytic Virus C134) for the Treatment of Malignant Glioma

NEW YORK and COLUMBUS, Ohio, May 16, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic ca...

MBIO - Mustang Bio to Present at the Cell & Gene Therapy USA Congress 2019

NEW YORK, May 13, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors...

MBIO - NetworkNewsBreaks - Mustang Bio, Inc. (NASDAQ: MBIO) Closes $31.6M Public Offering

Mustang Bio (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases, recently closed its underwritten public offering o...
MBIO - Mustang Bio beats by $0.03

Mustang Bio (NASDAQ: MBIO ): Q1 GAAP EPS of -$0.34  beats by $0.03 . More news on: Mustang Bio, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

MBIO - Mustang Bio Reports First Quarter 2019 Financial Results and Recent Corporate Highlights

NEW YORK, May 10, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors...

MBIO - Mustang Bio Announces Full Exercise of Option

NEW YORK, May 08, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors...
MBIO - Mustang Bio Announces City of Hope Opens First-of-Its-Kind Multiple Myeloma CAR T Cell Therapy Trial Targeting CS1 Protein

NEW YORK, May 08, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors...

MBIO - Mustang Bio off 12% after pricing stock offering

Mustang Bio ( MBIO -11.6% ) is down on almost 50% higher volume in reaction to its public offering of 6.875M common shares at $4 per share. More news on: Mustang Bio, Inc., Healthcare stocks news, Stocks on the move, Read more ...

MBIO - Mustang Bio Announces Pricing of Public Offering of Common Stock

NEW YORK, April 30, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumo...
Previous 10 Next 10